A burgeoning telehealth startup, MEDVi, heralded by The New York Times as a prime example of an AI-powered venture reaching…
Read More
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025
The pharmaceutical industry’s financial landscape is undergoing a significant transformation, marked by the continued brand dominance of Merck’s Keytruda (pembrolizumab)…
Read More
Pharma 50: The 50 Best-Selling Drugs of FY2025
The fiscal year 2025 concluded with a dramatic reshaping of the pharmaceutical industry’s top echelons, marked by intense competition at…
Read More
Eli Lilly Ascends to Pharma’s Top Revenue Spot Amidst Oral GLP-1 Approval, Yet Wall Street Remains Unconvinced.
Eli Lilly and Company, a venerable titan in the pharmaceutical industry, has achieved an unprecedented milestone, claiming the top spot…
Read More
Rethinking Evidence Generation for Ultra-Rare Diseases
Developing effective treatments for ultra-rare diseases has long presented a profound paradox for the biopharmaceutical industry and regulatory bodies. While…
Read More
A Billion-Dollar Telehealth Empire Built on Regulatory Cracks: The Medvi Controversy
Medvi, a telehealth company recently profiled by The New York Times as an AI-powered success story, is projected by its…
Read More
New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component
In the wake of The New York Times’ April 2 profile, which painted MEDVi CEO Matthew Gallagher as a "vibe-coded…
Read More
Sai Life Sciences’ Biotech Pitch Day 2026 Spotlights Pioneering Early-Stage Biotech Innovations Addressing Critical Unmet Medical Needs
Sai Life Sciences recently convened its highly anticipated Biotech Pitch Day 2026 at its strategically located Boston-area site, gathering a…
Read More
Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity market
The landscape of obesity treatment, a market projected to reach a staggering $1 trillion, is undergoing a profound transformation. While…
Read More
Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput
Immuto Scientific, a pioneering company co-founded in 2018 by electrical engineers Dr. Faraz A. Choudhury (CEO) and Dr. Daniel Benjamin…
Read MoreYOU MAY HAVE MISSED
